IL137388A - Absorbable microparticles - Google Patents
Absorbable microparticlesInfo
- Publication number
- IL137388A IL137388A IL13738899A IL13738899A IL137388A IL 137388 A IL137388 A IL 137388A IL 13738899 A IL13738899 A IL 13738899A IL 13738899 A IL13738899 A IL 13738899A IL 137388 A IL137388 A IL 137388A
- Authority
- IL
- Israel
- Prior art keywords
- absorbable
- microparticles
- absorbable microparticles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1539498A | 1998-01-29 | 1998-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL137388A true IL137388A (en) | 2005-05-17 |
Family
ID=21771154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13738899A IL137388A (en) | 1998-01-29 | 1999-01-20 | Absorbable microparticles |
| IL13738800A IL137388A0 (en) | 1998-01-29 | 2000-01-20 | Absorbable microparticles |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13738800A IL137388A0 (en) | 1998-01-29 | 2000-01-20 | Absorbable microparticles |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060210641A1 (xx) |
| EP (1) | EP1053020B1 (xx) |
| JP (2) | JP3842042B2 (xx) |
| CN (1) | CN1289256A (xx) |
| AR (1) | AR014510A1 (xx) |
| AT (1) | ATE262926T1 (xx) |
| AU (1) | AU2329199A (xx) |
| CA (1) | CA2318152A1 (xx) |
| DE (1) | DE69916031T2 (xx) |
| DK (1) | DK1053020T3 (xx) |
| ES (1) | ES2217738T3 (xx) |
| HU (1) | HUP0101250A3 (xx) |
| IL (2) | IL137388A (xx) |
| NO (1) | NO20003810L (xx) |
| PL (1) | PL193111B1 (xx) |
| PT (1) | PT1053020E (xx) |
| RU (1) | RU2237471C2 (xx) |
| TW (1) | TWI255721B (xx) |
| WO (1) | WO1999038536A1 (xx) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413539B1 (en) * | 1996-10-31 | 2002-07-02 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US6756480B2 (en) | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| AU2002214942A1 (en) * | 2000-11-16 | 2002-05-27 | Novo-Nordisk A/S | Analogues and derivatives of gastrin releasing peptide (grp) |
| FR2825273B1 (fr) * | 2001-05-29 | 2006-11-24 | Oreal | Composition pour le traitement des signes cutanes du vieillissement |
| CA2551039C (en) | 2003-12-16 | 2013-01-29 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R | Analogues of glp-1 |
| JP2007517913A (ja) * | 2004-01-13 | 2007-07-05 | バソジェニックス ファーマシューティカルズ， インコーポレイテッド | カルシトニン遺伝子関連ペプチドを投与することによって急性心筋梗塞を処置するための方法およびカルシトニン遺伝子関連ペプチドを含有する組成物 |
| JP2007517912A (ja) * | 2004-01-13 | 2007-07-05 | バソジェニックス ファーマシューティカルズ， インコーポレイテッド | 心脈管および腎臓の適応症のための制御放出ｃｇｒｐ送達組成物 |
| PT2118123E (pt) | 2007-01-31 | 2016-02-10 | Harvard College | Péptidos de p53 estabilizados e suas utilizações |
| ES2430067T3 (es) | 2007-03-28 | 2013-11-18 | President And Fellows Of Harvard College | Polipéptidos cosidos |
| WO2009035540A2 (en) | 2007-09-07 | 2009-03-19 | Ipsen Pharma S.A.S. | Analogues of exendin-4 and exendin-3 |
| MX2011000147A (es) | 2008-07-04 | 2011-05-24 | Traslational Cancer Drugs Pharma S L | Metodos para el tratamiento y diagnostico del cancer. |
| CN102170896A (zh) | 2008-08-07 | 2011-08-31 | 益普生制药股份有限公司 | 糖依赖性胰岛素释放肽的截短类似物 |
| AU2009280017B2 (en) | 2008-08-07 | 2013-01-10 | Ipsen Pharma S.A.S. | Analogues of glucose-dependent insulinotropic polypeptide |
| AU2009280021B2 (en) | 2008-08-07 | 2012-10-04 | Ipsen Pharma S.A.S. | Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal |
| WO2010092218A2 (es) | 2009-02-12 | 2010-08-19 | Proyecto De Biomedicina Cima, S.L. | Uso de la cardiotrofina-1 para el tratamiento de enfermedades metabólicas |
| MX2012000757A (es) | 2009-07-22 | 2012-08-03 | Ipsen Pharma Sas | Analogos de factor de crecimiento insulinoide tipo 1 (igf-1) que tienen sustitucion de aminoacidos en la posicion 59. |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| CA2807942C (en) * | 2010-08-10 | 2021-07-27 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
| WO2012021874A1 (en) | 2010-08-13 | 2012-02-16 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with thioether linkers |
| EA018472B1 (ru) * | 2010-09-15 | 2013-08-30 | Открытое Акционерное Общество "Протек" | Частицы, содержащие эритропоэтин, для лечения и профилактики неврологических и гематологических заболеваний и нарушений |
| WO2012172433A2 (en) * | 2011-06-14 | 2012-12-20 | Ipsen Pharma S.A.S. | A sustained-release composition containing peptides as active ingredient |
| BR112014009418A2 (pt) | 2011-10-18 | 2017-04-18 | Aileron Therapeutics Inc | macrociclos peptidomiméticos |
| CN103957898B (zh) | 2011-11-18 | 2016-02-24 | 瑞泽恩制药公司 | 聚合物蛋白微粒 |
| EP2819688A4 (en) | 2012-02-15 | 2015-10-28 | Aileron Therapeutics Inc | TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES |
| AU2013221432B2 (en) | 2012-02-15 | 2018-01-18 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| JP6526563B2 (ja) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス，インコーポレイテッド | 二置換アミノ酸ならびにその調製および使用の方法 |
| EP3107563B1 (en) | 2014-02-21 | 2021-04-07 | Ecole Polytechnique Fédérale de Lausanne (EPFL) EPFL-TTO | Glycotargeting therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| CA2961258A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| CN107614003A (zh) | 2015-03-20 | 2018-01-19 | 艾瑞朗医疗公司 | 拟肽大环化合物及其用途 |
| WO2017077066A1 (en) | 2015-11-06 | 2017-05-11 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same |
| US11253579B2 (en) | 2017-06-16 | 2022-02-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| CN113281317B (zh) * | 2021-05-14 | 2022-04-29 | 北京指真生物科技有限公司 | 一种含有花菁类化合物的编码微球及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US5385738A (en) * | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
| JPH0778017B2 (ja) * | 1985-12-28 | 1995-08-23 | 住友製薬株式会社 | パルス的かつ持続放出性製剤 |
| US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5077049A (en) * | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
| CA2099376A1 (en) * | 1991-01-03 | 1992-07-04 | Henry E. Auer | Stabilization of proteins by cationic biopolymers |
| CA2114122A1 (en) * | 1991-07-24 | 1993-02-04 | Thomas Sai Ying Ko | Therapeutic compositions and methods |
| US5366756A (en) * | 1992-06-15 | 1994-11-22 | United States Surgical Corporation | Method for treating bioabsorbable implant material |
| US5672659A (en) * | 1993-01-06 | 1997-09-30 | Kinerton Limited | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| EP0626170A3 (en) * | 1993-05-10 | 1996-03-27 | Sandoz Ltd | Stabilization of pharmacoligically active compounds in controlled release compositions. |
| EP0712421A1 (en) * | 1993-07-23 | 1996-05-22 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5612052A (en) * | 1995-04-13 | 1997-03-18 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US5665702A (en) * | 1995-06-06 | 1997-09-09 | Biomeasure Incorporated | Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| US5795922A (en) * | 1995-06-06 | 1998-08-18 | Clemson University | Bone cement composistion containing microencapsulated radiopacifier and method of making same |
| KR100210509B1 (ko) * | 1996-01-10 | 1999-07-15 | 성재갑 | 지속성 동물 성장 호르몬 제형 및 이의 제조 방법 |
-
1999
- 1999-01-20 PT PT99903216T patent/PT1053020E/pt unknown
- 1999-01-20 PL PL342662A patent/PL193111B1/pl not_active IP Right Cessation
- 1999-01-20 AT AT99903216T patent/ATE262926T1/de not_active IP Right Cessation
- 1999-01-20 IL IL13738899A patent/IL137388A/xx unknown
- 1999-01-20 WO PCT/US1999/001180 patent/WO1999038536A1/en active IP Right Grant
- 1999-01-20 HU HU0101250A patent/HUP0101250A3/hu unknown
- 1999-01-20 ES ES99903216T patent/ES2217738T3/es not_active Expired - Lifetime
- 1999-01-20 EP EP99903216A patent/EP1053020B1/en not_active Expired - Lifetime
- 1999-01-20 RU RU2000122622A patent/RU2237471C2/ru not_active IP Right Cessation
- 1999-01-20 AU AU23291/99A patent/AU2329199A/en not_active Abandoned
- 1999-01-20 CN CN99802517A patent/CN1289256A/zh active Pending
- 1999-01-20 CA CA002318152A patent/CA2318152A1/en not_active Abandoned
- 1999-01-20 DE DE69916031T patent/DE69916031T2/de not_active Expired - Fee Related
- 1999-01-20 DK DK99903216T patent/DK1053020T3/da active
- 1999-01-20 JP JP2000529268A patent/JP3842042B2/ja not_active Expired - Fee Related
- 1999-01-28 AR ARP990100340A patent/AR014510A1/es not_active Application Discontinuation
- 1999-01-28 TW TW088101329A patent/TWI255721B/zh not_active IP Right Cessation
-
2000
- 2000-01-20 IL IL13738800A patent/IL137388A0/xx unknown
- 2000-07-25 NO NO20003810A patent/NO20003810L/no unknown
-
2004
- 2004-09-13 JP JP2004265825A patent/JP2005047928A/ja active Pending
-
2006
- 2006-03-20 US US11/385,030 patent/US20060210641A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2217738T3 (es) | 2004-11-01 |
| JP2005047928A (ja) | 2005-02-24 |
| TWI255721B (en) | 2006-06-01 |
| JP3842042B2 (ja) | 2006-11-08 |
| US20060210641A1 (en) | 2006-09-21 |
| HUP0101250A3 (en) | 2006-06-28 |
| IL137388A0 (en) | 2001-07-24 |
| AR014510A1 (es) | 2001-02-28 |
| CN1289256A (zh) | 2001-03-28 |
| HUP0101250A2 (hu) | 2001-08-28 |
| DE69916031T2 (de) | 2005-02-17 |
| RU2237471C2 (ru) | 2004-10-10 |
| ATE262926T1 (de) | 2004-04-15 |
| DK1053020T3 (da) | 2004-07-26 |
| PL193111B1 (pl) | 2007-01-31 |
| AU2329199A (en) | 1999-08-16 |
| PT1053020E (pt) | 2004-06-30 |
| NO20003810L (no) | 2000-09-13 |
| JP2002501908A (ja) | 2002-01-22 |
| EP1053020B1 (en) | 2004-03-31 |
| DE69916031D1 (de) | 2004-05-06 |
| PL342662A1 (en) | 2001-07-02 |
| NO20003810D0 (no) | 2000-07-25 |
| EP1053020A1 (en) | 2000-11-22 |
| CA2318152A1 (en) | 1999-08-05 |
| WO1999038536A1 (en) | 1999-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL137388A0 (en) | Absorbable microparticles | |
| HUP9902797A3 (en) | Microparticles | |
| GB0000446D0 (en) | Early entry | |
| AU140490S (en) | Action trooper | |
| HUP9903290A3 (en) | Sulfanilsilanes | |
| HK1045694A1 (en) | Pyrazol-carboxanilide fungizide | |
| IL137349A0 (en) | Process for making absorbable microparticles | |
| DE69914921D1 (en) | Phenyl-xanthinderivate | |
| GB0004234D0 (en) | Early entry | |
| GB0010544D0 (en) | Early entry | |
| DE69821502D1 (en) | Boroskop | |
| IL142061A0 (en) | Interferon-epsilon | |
| GB9806966D0 (en) | Bioloically modified device | |
| PL347427A1 (en) | Thiazole-derivatives | |
| GB9909183D0 (en) | Early entry | |
| HUP0102261A3 (en) | Coffee-grinder | |
| GB9902662D0 (en) | Early entry | |
| DE69912430D1 (en) | Hydroformylierungsreaktionen | |
| SG75833A1 (en) | Catalytic microparticles | |
| GB9919461D0 (en) | Early entry | |
| GB9824111D0 (en) | Sawbench | |
| PL108656U1 (en) | Catch | |
| PL108835U1 (en) | Catch | |
| TW346913U (en) | Rapidly assembling-type chan-plate | |
| GB9820950D0 (en) | Early Entry |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed |